Announce Date | 08/07/2025 |
EPS Normalized Actual | $1.66 (Beat by $0.15) |
EPS GAAP Actual | $1.66 (Beat by $0.15) |
Revenue Actual | $0.457106B |
Revenue Surprise | Beat by $457.106M |
Announce Date | 12/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.51 |
EPS GAAP Estimate | $1.51 |
Revenue Estimate | $0.4343B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2027 | 8.15 | 17.78 | 8.01283 | 8.27409 | 1 |
Jun 2026 | 0 | INF | 0 | 0 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.51 | 1.51 | 0.457106B | 10.33% | 457.11M |
FQ1 2025 (Mar 2025) | 1.64 | 0.35425 | 0.466055B | 11.46% | 50.26M |
FQ4 2024 (Dec 2024) | 2.03 | 0.93 | 0.447729B | 12.17% | 53.35M |
FQ3 2024 (Sep 2024) | 1.22 | -0.06 | 0.4174B | 11.63% | 18.78M |
FQ2 2024 (Jun 2024) | 1.31 | 1.31 | 0.409907B | 11.23% | 409.91M |
FQ1 2024 (Mar 2024) | 0.95 | -0.06 | 0.412658B | 10.56% | -20.24M |
FQ4 2023 (Dec 2023) | 1 | 1 | 0.393242B | 7.61% | 393.24M |
FQ3 2023 (Sep 2023) | 0.26 | 0.26 | 0.368845B | 3.87% | 368.85M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
1.51
Consensus Revenue Estimates
0.4343B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 2.25 | -- | 2.20241 | 2.29584 | 1 |
FQ4 2026 (Dec 2026) | 2.33 | -- | 2.28071 | 2.37747 | 1 |
FQ3 2026 (Sep 2026) | 1.73 | -- | 1.69341 | 1.76525 | 1 |
FQ1 2026 (Mar 2026) | 1.83 | 10.38 | 1.83 | 1.83 | 0 |
FQ4 2025 (Dec 2025) | 1.51 | -34.44 | 1.51 | 1.51 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 0.53B | -- | 0.52B | 0.53B | 2 |
FQ4 2026 (Dec 2026) | 0.51B | -- | 0.5B | 0.52B | 1 |
FQ3 2026 (Sep 2026) | 0.48B | -- | 0.47B | 0.49B | 1 |
FQ1 2026 (Mar 2026) | 0.45B | -2.72 | 0.45B | 0.45B | 0 |
FQ4 2025 (Dec 2025) | 0.43B | -3.09 | 0.43B | 0.43B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.51 | 1.51 | 100% | |
FQ1 2025 (Mar 2025) | 1.28575 | 1.64 | 0.35425 | 21.6% |
FQ4 2024 (Dec 2024) | 1.1 | 2.03 | 0.93 | 45.81% |
FQ3 2024 (Sep 2024) | 1.28 | 1.22 | -0.06 | -4.92% |
FQ2 2024 (Jun 2024) | 1.31 | 1.31 | 100% | |
FQ1 2024 (Mar 2024) | 1.01 | 0.95 | -0.06 | -6.32% |
FQ4 2023 (Dec 2023) | 1 | 1 | 100% | |
FQ3 2023 (Sep 2023) | 0.26 | 0.26 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $0.46B | $457.11M | 100% |
FQ1 2025 (Mar 2025) | $0.42B | $0.47B | $50.26M | 10.78% |
FQ4 2024 (Dec 2024) | $0.39B | $0.45B | $53.35M | 11.92% |
FQ3 2024 (Sep 2024) | $0.4B | $0.42B | $18.78M | 4.5% |
FQ2 2024 (Jun 2024) | $0B | $0.41B | $409.91M | 100% |
FQ1 2024 (Mar 2024) | $0.43B | $0.41B | $-20.24M | -4.9% |
FQ4 2023 (Dec 2023) | $0B | $0.39B | $393.24M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.37B | $368.85M | 100% |